Revised SPC: Evotaz (atazanavir and cobicistat) 300mg/150mg film-coated tablets
The SPC has been updated with data following the 5-year marketing authorisation renewal. Additionally, the black triangle has been removed from the product information.
Source:
electronic Medicines compendium